New Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 102703 | AZD-8835 | 1620576-64-8 | ≧98.0% |  |
| AZD8835 is a potent and selective inhibitor of PI3Kalpha and PI3Kdelata with excellen | ||||
| 611902 | PF-04979064 | 1220699-06-8 | ≧98.0% |  |
| PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
| 6111110 | Nastorazepide | 209219-38-5 | 98% |  |
| Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
| 16122906 | Brivaracetam | 357336-20-0 | 98% |  |
| Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra | ||||
| 185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% |  |
| TRILACICLIB (G1T28), A HIGHLY POTENT, TRANSIENT CDK 4/6 INHIBITOR WITHIC50s OF 1 nM A | ||||
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | _1360460-82-7.png) |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 19132 | Cilofexor ( GS-9674 ) | 1418274-28-8 | ≧98.0% |  |
| Cilofexor (also known as GS-9674) is a nonsteroidal farnesoid X receptor (FXR) agonis | ||||
| 512193 | ITI-214(phosphate) | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||
| 6111901 | UNC2541 | 1612782-86-1 | 98% Min. |  |
| UNC2541 is a potent and MerTK-specific inhibitor and exhibits sub-micro molar inhibit | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 16122809 | Elacestrant | 722533-56-4 | ≧98.0% |  |
| Elacestrant, also known as RAD1901, is an orally available, selective estrogen recept | ||||